Pharmaceutical spend continues to be a main cost driver in the health care system, while additional governmental regulations challenge payers and providers. Despite factors in the marketplace that are out of our control, we are proud to have delivered a single-digit drug trend rate to our clients in 2015, based on total cost.
Learn more about all of the efforts Navitus has in place today to counter drug trend.
Exela Pharma Sciences, in association with marketer X-Gen Pharmaceuticals, Inc., is voluntarily recalling lot number PLND1613 of Ibuprofen Lysine Injection, 20 mg /2 mL (10 mg/mL), vials to the hospital or user level.
Hospira, Inc. voluntarily recalled one lot of vancomycin Hcl for Injection drug. Hospira Inc. is a Pfizer Company. It recalled the drug because some vials may have solid particles in them.
Contact Us | Careers | MedicareRx (PDP) | Navi-Gate Rx | Site Map | Confidentiality Statement | Vendor/FDR | Download Adobe Reader